Related Experiment Videos

Reply to ‘Evidence for harm, comment on . . .’ by Kripke & Langer

Anton Pottegård, Søren Friis, Morten Andersen

British Journal of Clinical Pharmacology

|August 2, 2014

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Impact of semaglutide introduction on the use of triptans: an interrupted-time series.

The journal of headache and pain·2026

Treatment Patterns and Experienced Effects of Semaglutide for Weight Management Among Adult Users in Denmark: A Community Pharmacy-Based Cross-Sectional Survey.

Diabetes, obesity & metabolism·2026

Use of Glucagon-Like Peptide-1 Receptor Agonists in Danish Adolescents and Young Adults 2018-2025.

Obesity (Silver Spring, Md.)·2026

Medication Exposure Definitions in Perinatal Pharmacoepidemiology: Implications for Pregnancy Studies.

Paediatric and perinatal epidemiology·2026

Comprehensive drug safety assessment of sodium-glucose co-transporter 2 inhibitors, glucagon-like peptide 1 receptor agonists, and dipeptidyl peptidase 4 inhibitors: A Danish population-based active comparator new user cohort study.

Diabetes research and clinical practice·2026

Time Windows Used When Identifying Current Drug Use and Polypharmacy.

Pharmacoepidemiology and drug safety·2026

See all related articles